Sort
130,381 grants matching “hiv”
Pittsburgh Center for HIV Protein Interactions (PCHPI)
$5,050,210Angela M. Gronenborn · University Of Pittsburgh At Pittsburgh · U54 · FY2024 · AI
Regional Prospective Observational Research in Tuberculosis (RePORT) International Coordinating Center (RICC) (RePORT RICC)
$5,050,000Michael Dignam · National Institute Of Allergy And Infectious Diseases · Y01 · FY2021 · AI
HIV CARE, SUPPORT AND TREATMENT: IMPLEMENTATION OF PROGRAMS FOR THE PREVENTION, C
$5,050,000Jeroen Van't Pad Bosch · Elizabeth Glaser Pediatric Aids Fdn · U2G · FY2015 · PS
Third Coast Center For AIDS Research
$5,048,227Richard T D'aquila · Northwestern University At Chicago · P30 · FY2021 · AI
Pittsburgh Center for HIV Protein Interactions (PCHPI)
$5,045,139Angela M. Gronenborn · University Of Pittsburgh At Pittsburgh · U54 · FY2025 · AI
Cell and Gene Therapy for HIV Cure
$5,044,836Keith R Jerome · Fred Hutchinson Cancer Research Center · UM1 · FY2019 · AI
PS10-1001, HIV PREVENTION PROJECTS
$5,044,684Deann Gruber · Louisiana State Department Of Health · U62 · FY2011 · PS
CIPRA-SA: Safeguard the household: comprehensive AIDS research: Extension
$5,044,510James Alasdair McIntyre · Wits Health Consortium (Pty), Ltd · U19 · FY2007 · AI
HIV Vaccine Design and Development Teams
$5,042,594 · N01 · FY2007 · AI
HIV VACCINE DESIGN AND DEVELOPMENT TEAMS, PART B-THERAPEUTIC VACCINES
$5,042,594John Eldridge · · N01 · FY2007 · AI
Combined Immunologic Approaches to Cure HIV-1
$5,042,075Dan H. Barouch · Beth Israel Deaconess Medical Center · UM1 · FY2019 · AI
PS12-1201 COMPREHENSIVE HIV PREVENTION PROJECT FOR HEALTH DEPTS
$5,041,420Jeanece Seals · Tennessee State Department Of Health · U62 · FY2012 · PS
Immunologic and Virologic Basis of RhCMV/SIV Vaccine-Induced Replication Arrest Efficacy
$5,039,342Louis J. Picker · Oregon Health & Science University · P01 · FY2023 · AI
HIV Prevention Trials Network: Network Laboratory
$5,037,579Susan H Eshleman · Johns Hopkins University · UM1 · FY2012 · AI
External Quality Assurance Program Oversight Laboratory (EQAPOL)
$5,036,820Thomas Denny · Duke University · N01 · FY2023 · AI
HIV Monoclonal Antibody Studies
$5,034,881Julie E. Ledgerwood · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Project 2 - GMP Manufacturing of mRNA Immunogens
$5,033,198Thomas N Denny · Duke University · U19 · FY2024 · AI
GH15-1551, MALAWI: STRENGTHENING HIGH QUALITY LABORATORY SERVICES SCALE-UP FOR HIV DIAGNOSIS, CARE, TREATMENT AND MONITORING IN MALAWI UNDER THE PRESIDENT'S EMERGENCY PLAN FOR AIDS RELIEF (PEPFAR)
$5,032,420Kanyenda Limbikani · University Research Co, Llc · U2G · FY2016 · GH
Reversing Immune Dysfunction for HIV-1 Eradication
$5,028,890Sumit K Chanda · Scripps Research Institute, The · UM1 · FY2025 · AI
Acute HIV-1 Infections Network Core
$5,022,534John Andrew Crump · Duke University · U19 · FY2011 · AI
University of North Carolina AIDS Clinical Trials Unit (UNC ACTU)
$5,018,251Joseph J. Eron · Univ Of North Carolina Chapel Hill · UM1 · FY2013 · AI
HIV Interactions In Viral Evolution
$5,014,695Bruce Edward Torbett · Seattle Children'S Hospital · U54 · FY2020 · AI
Identification of novel Th17 inducing CTLR agonists for vaccines against mycobacterium tuberculosis
$5,009,797Jay Evans · University Of Montana · N01 · FY2018 · AI
GH11-11108: TECHNICAL ASSISTANCE TO THE MOH FOR HIV SVC (PEPFAR) - Mozambique
$5,009,395Wafaa M. El-Sadr · Columbia University Health Sciences · U2G · FY2015 · GH
INCREASING ACCESS TO HIV CONFIDENTIAL COUNSELING AND TESTING (VCT) AND ENHA
$5,008,736Douglas F. Call · Population Services International · U62 · FY2011 · PS